RecruitingOverweight or Obesity
Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity
Eligible age
18–65 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study will test a study drug called REGN20934 to see how safe and well tolerated this drug is, as well as how the drug is processed in the body for participants with overweight or obesity. The study is looking at: * What side effects REGN20934 might cause * How much REGN20934 is in the blood at different times * If the body makes antibodies to REGN20934
Sponsor: Regeneron Pharmaceuticals
Where it's recruiting
California
Glendale
Source: ClinicalTrials.gov · NCT07594093 · last updated 2026-09-25